Myovant Sciences Ltd. Deferred Tax Assets, Gross
Myovant Sciences Ltd. had Deferred Tax Assets, Gross of $246.46 million as of 2022-03-31, per its 10-K filed 2022-05-11.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2022-05-11
- 2022-03-31: Deferred Tax Assets, Gross $246.46M.
- 2021-03-31: Deferred Tax Assets, Gross $210.54M.
- 2020-03-31: Deferred Tax Assets, Gross $160.28M.
- 2019-03-31: Deferred Tax Assets, Gross $92.74M.
| Period end | Deferred Tax Assets, Gross | Deferred Tax Assets, Gross as first filed |
|---|---|---|
| 2022-03-31 | $246.46M 10-K · filed 2022-05-11 | |
| 2021-03-31 | $210.54M 10-K · filed 2022-05-11 | |
| 2020-03-31 | $160.28M 10-K · filed 2021-05-11 | |
| 2019-03-31 | $92.74M 10-K · filed 2020-05-18 | |
| 2018-03-31 | $21.54M 10-K · filed 2019-05-24 | |
| 2017-03-31 | $7.86M 10-K · filed 2018-06-07 | $7.61M 10-K · filed 2017-06-14 |
| 2016-03-31 | $0.00 10-K · filed 2017-06-14 |